Synendos Therapeutics is a biopharmaceutical company that aims to develop breakthrough safe and effective therapies for unmet needs in neuropsychiatric disorders through modulation of a new drug target in the endocannabinoid system that enables restoration of natural functioning of the brain.
Our mission is to advance the preclinical and clinical development of a new class of small molecules that act as selective endocannabin...
Synendos Therapeutics is a biopharmaceutical company that aims to develop breakthrough safe and effective therapies for unmet needs in neuropsychiatric disorders through modulation of a new drug target in the endocannabinoid system that enables restoration of natural functioning of the brain.
Our mission is to advance the preclinical and clinical development of a new class of small molecules that act as selective endocannabinoid reuptake inhibitors (SERIs).
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.